Trials / Completed
CompletedNCT01523873
Observational Post-marketing Study on the Safety and Efficacy of Dotarem® (SECURE Study)
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 35,921 (actual)
- Sponsor
- Guerbet · Industry
- Sex
- All
- Age
- —
- Healthy volunteers
- Accepted
Summary
The main purpose of this study is to prospectively assess the general safety profile of Dotarem
Conditions
Timeline
- Start date
- 2008-11-01
- Primary completion
- 2013-07-01
- Completion
- 2013-07-01
- First posted
- 2012-02-01
- Last updated
- 2017-02-24
- Results posted
- 2016-01-22
Locations
10 sites across 10 countries: Argentina, Austria, China, France, Germany, India, Italy, Saudi Arabia, Spain, United Kingdom
Source: ClinicalTrials.gov record NCT01523873. Inclusion in this directory is not an endorsement.